Double bottom in GILDWonderful double bottom pattern spotted in GILD. It hasn't broken out yet. This chart is for educational purposes only. Please consult your financial advisor before making any buy or sell decision.
1.10 USD
426.34 M USD
25.52 B USD
About Gilead Sciences, Inc.
Sector
Industry
CEO
Daniel P. O'Day
Website
Headquarters
Foster City
Founded
1987
ISIN
ARBCOM4601C4
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
Related stocks
Gildgilead science is in parallel channel since last 6 years and forming bearish downward pattern.
This is not good as follow through for the long pole is missing.
Manage risks and Own profitsHere's a rotated Trade Box For GLD
PLease refere to old trade boxes to get a keymap or feel free to PM!
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
GILD5050564
Gilead Sciences, Inc. 1.2% 01-OCT-2027Yield to maturity
—
Maturity date
Oct 1, 2027
GILD.GO
Gilead Sciences, Inc. 5.65% 01-DEC-2041Yield to maturity
—
Maturity date
Dec 1, 2041
GILD4184058
Gilead Sciences, Inc. 4.5% 01-FEB-2045Yield to maturity
—
Maturity date
Feb 1, 2045
GILD5050849
Gilead Sciences, Inc. 2.8% 01-OCT-2050Yield to maturity
—
Maturity date
Oct 1, 2050
GILD5648609
Gilead Sciences, Inc. 5.55% 15-OCT-2053Yield to maturity
—
Maturity date
Oct 15, 2053
GILD5939389
Gilead Sciences, Inc. 5.1% 15-JUN-2035Yield to maturity
—
Maturity date
Jun 15, 2035
GILD5050565
Gilead Sciences, Inc. 1.65% 01-OCT-2030Yield to maturity
—
Maturity date
Oct 1, 2030
GILD5939388
Gilead Sciences, Inc. 4.8% 15-NOV-2029Yield to maturity
—
Maturity date
Nov 15, 2029
GILD4104362
Gilead Sciences, Inc. 4.8% 01-APR-2044Yield to maturity
—
Maturity date
Apr 1, 2044
GILD5648658
Gilead Sciences, Inc. 5.25% 15-OCT-2033Yield to maturity
—
Maturity date
Oct 15, 2033
GILD5939385
Gilead Sciences, Inc. 5.5% 15-NOV-2054Yield to maturity
—
Maturity date
Nov 15, 2054
See all GILDD bonds
Curated watchlists where GILDD is featured.
